Home > National Drug Code (NDC) > Treatment Set TS332229

Treatment Set TS332229 - 49288-0672-3 - (Treatment Set TS332229)

Alphabetical Index


Drug Information of Treatment Set TS332229

Product NDC: 49288-0672
Proprietary Name: Treatment Set TS332229
Non Proprietary Name: Treatment Set TS332229
Active Ingredient(s): .002; .0004; .002; 4000; .002; .002; .001; .001; .002; 400; 400; 400; .002; .002; .002; .002; .002; .002; 4000; .002; .002; .002; .002; .002    g/mL; g/mL; g/mL; [AU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL; [BAU]/mL; g/mL; [AU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL & nbsp;   Treatment Set TS332229
Administration Route(s): INTRADERMAL; SUBCUTANEOUS
Dosage Form(s): INJECTION, SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Treatment Set TS332229

Product NDC: 49288-0672
Labeler Name: Antigen Laboratories, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: BLA102223
Marketing Category: BLA
Start Marketing Date: 19861031

Package Information of Treatment Set TS332229

Package NDC: 49288-0672-3
Package Description: 10 mL in 1 VIAL, MULTI-DOSE (49288-0672-3)

NDC Information of Treatment Set TS332229

NDC Code 49288-0672-3
Proprietary Name Treatment Set TS332229
Package Description 10 mL in 1 VIAL, MULTI-DOSE (49288-0672-3)
Product NDC 49288-0672
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Treatment Set TS332229
Dosage Form Name INJECTION, SOLUTION
Route Name INTRADERMAL; SUBCUTANEOUS
Start Marketing Date 19861031
Marketing Category Name BLA
Labeler Name Antigen Laboratories, Inc.
Substance Name ACER NEGUNDO POLLEN; ALTERNARIA ALTERNATA; AMARANTHUS RETROFLEXUS POLLEN; AMBROSIA ARTEMISIIFOLIA POLLEN; ASPERGILLUS FUMIGATUS; CANIS LUPUS FAMILIARIS HAIR; CARYA ALBA POLLEN; CARYA ILLINOINENSIS POLLEN; CLADOSPORIUM HERBARUM; CYNODON DACTYLON POLLEN; DERMATOPHAGOIDES FARINAE; DERMATOPHAGOIDES PTERONYSSINUS; FRAXINUS AMERICANA POLLEN; IVA ANNUA VAR. ANNUA POLLEN; JUGLANS NIGRA POLLEN; JUNIPERUS ASHEI POLLEN; PENICILLIUM CHRYSOGENUM VAR. CHRYSOGENUM; PERIPLANETA AMERICANA; PHLEUM PRATENSE POLLEN
Strength Number .002; .0004; .002; 4000; .002; .002; .001; .001; .002; 400; 400; 400; .002; .002; .002; .002; .002; .002; 4000; .002; .002; .002; .002; .002
Strength Unit g/mL; g/mL; g/mL; [AU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL; [BAU]/mL; g/mL; [AU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL; g/mL; [BAU]/mL; g/mL; g/mL; g/mL; g/mL; g/mL
Pharmaceutical Classes Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Insect Protein Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Antigens, Dermatophagoides [Chemical/Ingredient],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Animal Hair Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fur [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Insect Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Insect Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Fungal Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Fungal Proteins [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Non-Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient],Standardized Pollen Allergenic Extract [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Increased IgG Production [PE],Pollen [Chemical/Ingredient],Allergens [Chemical/Ingredient]

Complete Information of Treatment Set TS332229


General Information